Impact of Microbe Literacy Initiative on Improved Vaccine Uptake in

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

This study is designed to assess the impact of the first introduction of microscope-based health education on people's attitude and practice towards disease prevention in Nepal, measured by vaccine acceptance rate. Such health education has an important role to play in communities where vaccine acceptance is low.

See also
	Status	Clinical Trial	Phase
	Completed	`NCT05875779` - Peer Education as a Strategy to Promote Vaccine Acceptance	N/A
	Completed	`NCT02196454` - Video to Promote HPV Vaccination	N/A

NCT number	NCT05378438
Study type	Interventional
Source	Nepal Health Research Council
Contact
Status	Not yet recruiting
Phase	N/A
Start date	July 15, 2022
Completion date	April 17, 2023

Impact of Microbe Literacy Initiative on Improved Vaccine Uptake in Peri-urban Slum Areas in Kathmandu, Nepal

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms